about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsFavorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationImmunotherapy of colorectal cancer.Mature CD8(+) T lymphocyte response to viral infection during fetal lifeGeneration of CD1 tetramers as a tool to monitor glycolipid-specific T cellsPhenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status.Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytesNatural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study.Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease.NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells.Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients.The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire.HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes.Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.Modulation of CD103 expression on human colon carcinoma-specific CTL.Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants.At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity.Molecular and Functional Characterization of Lymphoid Progenitor Subsets Reveals a Bipartite Architecture of Human Lymphopoiesis.Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes.A new HLA-B*27 allele (B*2719) identified in a Lebanese patient affected with ankylosing spondylitis.Polymorphisms in oxidative stress-related genes are associated with nasopharyngeal carcinoma susceptibility.Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells.Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.[Natural killer lymphocyte activation in response to stress]Correction: Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes.[NK cells: a major role in the antitumoral immunomodulation in CML]Expression of CD94 by -differentiated NK cells correlates with the and acquisition of cytotoxic featuresAHR: leukemic countermeasure against NK cellsCD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA InteractionsNKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer TreatmentGenomic diversity of natural killer cell receptor genes in three populations[Subtypes of the HLA-B27 molecule and association with spondylarthropathies]
P50
Q26751011-0C6D5596-2005-4BE0-8270-FC504107399EQ34649004-EA382F11-1A12-4654-A252-DF61A6D8EEFBQ34991918-E7A25621-1DAE-476D-8FC8-C77C52AB67FAQ35019349-95B8ADD0-1097-43A9-A13E-C91565D800A0Q35153216-C925B402-F1C9-4111-86B6-3E6C7E87FB36Q36060273-D4761A1F-47CF-4FE6-BC66-999C96469598Q37012676-A89EC6EA-EA04-45E2-AB0B-B2B0BA0F947AQ38376608-9389CB01-2877-4C1C-A9FF-AE3A59E790C4Q38973867-A503F744-87F9-42B1-9B9A-E6AF348B05C3Q39538920-DE00E967-8E7B-4807-A6B7-09CC5AB33F44Q39946280-EA1081B5-46F8-49B5-AF67-06B5F29D43A4Q40296130-F84CC19F-C629-4E61-A62A-4EA88694949DQ40633802-0AA3A808-DD2E-4F5C-A14A-49C56F06F474Q40656388-CD5A4FFD-B776-4617-A2D2-C35796940421Q40735567-1AACAA33-91E0-4498-8CCE-ED3E53FBF90EQ40821887-A903252D-FF71-4A98-80E3-58D60917B0A7Q40869764-C483C496-F9F1-49AD-8530-9641D39190E4Q40871021-533D74F5-E2D8-4CEC-A592-4982F11927FBQ41137052-0E750269-7CEF-4237-BA4C-5CFED7D5CA26Q42209070-9CA565EA-D284-4A8F-8CA3-446DB9EA0CD3Q42399890-A5D1EDE7-ADA3-4D51-8D20-9E095531B5D2Q42806401-B5343BBE-652A-4B7C-9879-291A8B331CCDQ43529469-923919F3-960A-4948-9A65-DDFD55A58C95Q44863213-4C103000-F0A9-48A9-B943-43B05F918B14Q46124973-BBEB05E1-EA30-4522-A551-A01A57C807DFQ47632634-617236E9-65F9-45F0-A9F6-402A4B3E8990Q48254996-D9A8C187-3E91-4C42-90FA-4304FAC1C83FQ48340661-349957B8-4EE3-4404-93E0-F358DB3CA162Q50456343-D44C6A12-9E25-4F92-8A98-099A33CFC9CAQ50700120-8F4C33CA-E796-4404-88EC-98C593F19EFDQ52119708-3E32A382-E3C7-43FF-BD4A-34E5A0AFA5B5Q54523675-9C9A0885-F156-4DBB-AF01-24529A697B16Q55554656-2BDC49FC-E378-403A-ACD8-93B731BD3866Q57179195-9B992379-B497-46A2-96BA-7731EA413223Q58125336-9B15A8EF-1AF5-4673-9650-C652A6FE172EQ58553033-58D18EB6-E483-4E10-8D9C-31E856032BF7Q60609019-A074A633-D00C-4EED-B530-08B2CBB7C80AQ64102223-6B662071-70A5-4C41-AD75-359156288A01Q73943144-EF0FEF88-B8B3-44B7-9EBB-C03DB31642AEQ74323570-1E50EF61-7103-4036-B75B-ED9463653086
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicolas Dulphy
@ast
Nicolas Dulphy
@en
Nicolas Dulphy
@es
Nicolas Dulphy
@nl
Nicolas Dulphy
@sl
type
label
Nicolas Dulphy
@ast
Nicolas Dulphy
@en
Nicolas Dulphy
@es
Nicolas Dulphy
@nl
Nicolas Dulphy
@sl
prefLabel
Nicolas Dulphy
@ast
Nicolas Dulphy
@en
Nicolas Dulphy
@es
Nicolas Dulphy
@nl
Nicolas Dulphy
@sl
P1053
J-5960-2017
P106
P21
P31
P3829
P496
0000-0002-1243-6456